Review: cellularity in bone marrow autografts for bone and fracture healing
American Journal of Physiology-Cell Physiology · 01.02.2023 · 324 (2) · C517-C531
DOI: 10.1152/ajpcell.00482.2022 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.02.2023. Verfasst von S Haeusner und 3 weiteren Autor:innen. Beteiligte Einrichtung: IZKF Group Tissue Regeneration in Musculoskeletal Diseases, University Hospital of Wuerzburg, Wuerzburg, Germany. Hauptthemen laut MEDLINE: Bone Marrow, Fracture Healing. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 89 Literaturangaben. Gefördert von: Bundesministerium für Bildung und Forschung, Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg.
Abstract (Originalsprache)
The use of autografts, as primary cell and tissue source, is the current gold standard approach to treat critical size bone defects and nonunion defects. The unique mixture of the autografts, containing bony compartments and bone marrow (BM), delivers promising results. Although BM mesenchymal stromal cells (BM-MSCs) still represent a major target for various healing approaches in current preclinical research and respective clinical trials, their occurrence in the human BM is typically low. In vitro expansion of this cell type is regulatory challenging as well as time and cost intensive. Compared with marginal percentages of resident BM-MSCs in BM, BM mononuclear cells (BM-MNCs) contained in BM aspirates, concentrates, and bone autografts represent a readily available abundant cell source, applicable within hours during surgical procedures without the need for time-consuming and regulatory challenging cell expansion. This benefit is one reason why autografting has become a clinical standard procedure. However, the exact anatomy and cellularity of BM-MNCs in humans, which is strongly correlated to their unique mode of action and wide application range remains to be elucidated. The aim of this review was to present an overview of the current knowledge on these specific cell types found in human BM, emphasize the contribution of BM-MNCs in bone healing, highlight donor site dependence, and discuss limitations in the current isolation and subsequent characterization procedures. Hereby, the most recent and relevant examples of human BM-MNC cell characterization, flow cytometric analyses, and findings are summarized, with a strong focus on bone therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IZKF Group Tissue Regeneration in Musculoskeletal Diseases, University Hospital of Wuerzburg, Wuerzburg, Germany.
- Bernhard-Heine-Center for Locomotion Research, University of Wuerzburg, Wuerzburg, Germany.
- Group for Hematology and Stem Cells, Institute for Medical Research, University of Belgrade, Belgrade, Serbia.
- Department of Trauma, Hand, Plastic and Reconstructive Surgery, University Hospital of Wuerzburg, Wuerzburg, Germany.
ORCID-Profile: S Haeusner, A Jauković, M Herrmann
Förderung
- Bundesministerium für Bildung und Forschung
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
Zitieren
APA
Haeusner, S., Jauković, A., Kupczyk, E., & Herrmann, M. (2023). Review: cellularity in bone marrow autografts for bone and fracture healing. American Journal of Physiology-Cell Physiology, 324(2), C517-C531. https://doi.org/10.1152/ajpcell.00482.2022
Vancouver
Haeusner S, Jauković A, Kupczyk E, Herrmann M. Review: cellularity in bone marrow autografts for bone and fracture healing. American Journal of Physiology-Cell Physiology. 2023;324(2):C517-C531. doi:10.1152/ajpcell.00482.2022
BibTeX
@article{Haeusner2023,
author = {Haeusner, S and Jauković, A and Kupczyk, E and Herrmann, M},
title = {Review: cellularity in bone marrow autografts for bone and fracture healing},
journal = {American Journal of Physiology-Cell Physiology},
year = {2023},
volume = {324},
number = {2},
pages = {C517--C531},
doi = {10.1152/ajpcell.00482.2022}
}
EUVIMED